Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Patogen Nord AS
AS
Active
Org 919870206
Klinkerveien 8, 8006
Bodø
Annen faglig, vitenskapelig og teknisk virksomhet ikke nevnt annet sted
·
NACE 74909
Est. 2017 · 8 years old
5 employees
Monitor
Share
Norway
/
Companies
/
Annen faglig, vitenskapelig og teknisk virksomhet ikke nevnt annet sted
/
Patogen Nord AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
31M
23M
16M
8M
0M
2019: 25M
25M
2019
2020: 24M (-4% vs 2019)
24M
-4%
2020
2021: 24M (0% vs 2020)
24M
0%
2021
2022: 23M (-4% vs 2021)
23M
-4%
2022
2023: 24M (+4% vs 2022)
24M
+4%
2023
EBITDA
NOK millions
6M
5M
3M
2M
0M
2019: 5M
5M
2019
2020: 4M (-20% vs 2019)
4M
-20%
2020
2021: 3M (-25% vs 2020)
3M
-25%
2021
2022: 1M (-67% vs 2021)
1M
-67%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
Income statement
NOK thousands
Item
2023
2022
2021
2020
2019
Revenue
23 765
23 036
24 377
24 436
25 405
Staff expenses
−3 794
−3 522
−3 605
−3 052
−2 705
EBITDA
791
687
3 475
4 233
4 503
Depreciation & amort.
−132
−225
−213
−213
−213
EBIT
659
463
3 261
4 020
4 289
Net financials
6
45
4
23
42
Profit before tax
665
508
3 266
4 044
4 331
Tax
146
112
719
895
955
Net profit
518
396
2 547
3 149
3 376
Balance sheet
NOK thousands
Item
2023
2022
2021
2020
2019
Total assets
6 280
6 414
9 400
9 731
11 633
Equity
2 866
2 848
2 452
2 905
2 756
Long-term debt
0
0
0
0
11
Short-term debt
3 413
3 566
6 948
6 826
8 866
Total debt
3 413
3 566
6 948
6 826
8 877
Financial ratios
5-year trend
EBITDA margin
3,3 %
This company
15,8 %
Market median
This company
Market median
79% below market
2019
2023
Equity ratio
45,6 %
This company
38,2 %
Market median
This company
Market median
19% above market
2019
2023
Return on equity
18,1 %
This company
18,4 %
Market median
This company
Market median
2% below market
2019
2023
Net profit margin
2,2 %
This company
8,1 %
Market median
This company
Market median
73% below market
2019
2023
Asset turnover
3,78×
This company
1,12×
Market median
This company
Market median
237% above market
2019
2023
Debt / equity
1,19×
This company
0,62×
Market median
This company
Market median
92% above market
2019
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
More on Patogen Nord AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
